Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C. P. A. A. van Roomen"'
Autor:
W. W. Kallemeijn, K.-Y. Li, M. D. Witte, A. R. A. Marques, J. Aten, S. Scheij, J.-B. Jiang, L. I. Willems, T. M. Voorn-Brouwer, C. P. A. A. van Roomen, R. Ottenhoff, R. G. Boot, H. van den Elst, M. T. C. Walvoort, B. I. Florea, J. D. C. Codxe9e, G. A. van der Marel, J. M. F. G. Aerts, H. S. Overkleeft
Publikováno v:
Angewandte Chemie - International Edition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=erc_________::11e57c6f100d4ca118a8d0769087a04c
Autor:
M de Boer, Wayne R. Thomas, Edward F. Knol, R.J.J. van Neerven, C. P. A. A. van Roomen, F.M. Davis
Publikováno v:
International Archives of Allergy and Immunology. 124:400-402
Background: As a result of the very efficient capture of allergens by IgE that focuses to CD23 on B cells or FcΕRI on dendritic cells, allergen-specific T cells can be activated after exposure to very low levels of allergens. This IgE-mediated aller
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cfe3619ab5da19d6ecc1c09801f6597
https://doi.org/10.1159/000053770
https://doi.org/10.1159/000053770
Publikováno v:
New Trends in Allergy V ISBN: 9783642627682
Non-anaphylactogenic anti-IgE mAb have been developed over the past decade to treat atopic allergies. These antibodies neutralize circulating IgE molecules, and thus prevent IgE from binding to its receptors, FCERI and CD23. Efficacy of anti-IgE trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a922201d2d06166568c3dda2a67bfffa
https://doi.org/10.1007/978-3-642-55994-5_36
https://doi.org/10.1007/978-3-642-55994-5_36
Autor:
C. P. A. A. van Roomen, E. Foppen, Johannes M. F. G. Aerts, Andries Kalsbeek, M. van Eijk, Elodie M. Girault, Roelof Ottenhoff, D. Herrera Moro Chao
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 10:154-154
Iminosugars are carbohydrate analogues currently used as therapeutic agents in the treatment of diabetes mellitus type 2 and Gaucher disease. The lypophilic iminosugar AMP-DMN (adamantine methyloxypentyl-deoxynojirimycin) has been proven to be the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d885b67f138105f0341426ca79841c99
https://doi.org/10.1007/s12467-012-0112-1
https://doi.org/10.1007/s12467-012-0112-1
Autor:
Milka Sokolović, Roelof Ottenhoff, Piter J. Bosma, Jan Aten, C. P. A. A. van Roomen, Aleksandar Sokolović, R.P.J. Oude Elferink, Johan K. Hiralall, A. K. Groen
Publikováno v:
Journal of Hepatology. 56:S159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d77e368f46970d79cc1d0b79134493e3
https://doi.org/10.1016/s0168-8278(12)60409-7
https://doi.org/10.1016/s0168-8278(12)60409-7
Autor:
Roelof Ottenhoff, Johannes M. F. G. Aerts, Elisa Lombardo, Florence Bietrix, C. P. A. A. van Roomen, Albert K. Groen
Publikováno v:
Chemistry and Physics of Lipids. 163:S14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4801de444e2682b62f354e8e659e4534
https://doi.org/10.1016/j.chemphyslip.2010.05.046
https://doi.org/10.1016/j.chemphyslip.2010.05.046